Site Map

Clinical Trial Results

Clinical Trial Results by Therapeutic Area

Bone/Osteoporosis
Cancer/Oncology
Diabetes/Endocrine
Mental Health/Neuroscience
Other

Clinical Trial Results by Product

Alimta® (pemetrexed)
Byetta® (exenatide)
Cymbalta® (duloxetine hydrochloride)
Evista® (raloxifene hydrochloride)
Forteo® (teriparatide [rDNA origin] injection)
Gemzar® (gemcitabine hydrochloride)
Glucagon for Injection (rDNA origin)
Humalog® (insulin lispro, rDNA origin)
Humatrope® (somatropin, rDNA Origin, for Injection)
Permax® (pergolide tablets, USP)
Prozac® (fluoxetine hydrochloride)
Strattera® (atomoxetine hydrochloride)
Symbyax™ (olanzapine and fluoxetine hydrochloride)
Xigris® (drotrecogin alfa [activated])
Yentreve® (duloxetine hydrochloride)
Zyprexa® (olanzapine)
Zyprexa® Intramuscular (olanzapine)

Initiated Clinical Trials

Bone/Osteoporosis
Cancer/Oncology
Cardiovascular
Diabetes/Endocrinology
Mental Health/Neuroscience
Other

Observational / Non-Interventional Studies

Initiated Observational / Non-Interventional Studies

Cancer/Oncology
Mental Health/Neuroscience

Publication Web Sites

Independent Audit

Terminology

Education

Alliances/Partnerships